Skip to main content
Livermore
Livermore
ZHEN

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

SAGE holding history

Sage Therapeutics, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SAGE overviewAll 13F holders of SAGEFull Q2 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of SAGE by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−874,166−100.0%Sold outHolders
Q2 2025874,166$7.97M<0.1%+392,389+81.4%AddedHolders
Q1 2025481,777$3.83M<0.1%−3,578−0.7%ReducedHolders
Q4 2024485,355$2.64M<0.1%−3,979−0.8%ReducedHolders
Q3 2024489,334$3.53M<0.1%−20,028−3.9%ReducedHolders
Q2 2024509,362$5.53M<0.1%−416,216−45.0%ReducedHolders
Q1 2024925,578$17.3M<0.1%−42,107−4.4%ReducedHolders
Q4 2023967,685$21.0M<0.1%−359,906−27.1%ReducedHolders
Q3 20231,327,591$27.3M<0.1%−388,677−22.6%ReducedHolders
Q2 20231,716,268$80.7M<0.1%+61,568+3.7%AddedHolders
Q1 20231,654,700$69.4M<0.1%+335,966+25.5%AddedHolders
Q4 20221,318,734$50.3M<0.1%+242,969+22.6%AddedHolders
Q3 20221,075,765$42.1M<0.1%+422,868+64.8%AddedHolders
Q2 2022652,897$21.1M<0.1%+481,867+281.7%AddedHolders
Q1 2022171,030$5.66M<0.1%−13,655−7.4%ReducedHolders
Q4 2021184,685$7.86M<0.1%−20,181−9.9%ReducedHolders
Q3 2021204,866$9.08M<0.1%−167,445−45.0%ReducedHolders
Q2 2021372,311$21.1M<0.1%+211,539+131.6%AddedHolders
Q1 2021160,772$12.0M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.